Skip to content
Disclosery

Maple-Brown Abbott Ltd: SRE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Maple-Brown Abbott Ltd on SRE, newest first. How the timeline and the estimate are built.

Maple-Brown Abbott Ltd held 1,320,706 SRE shares at 2025-03-31 per its 13F-HR filed 2025-05-13.

the latest 13F is the newest step

  1. period ended2025-03-31
    13F 1,320,706 shares
    Change vs previous 13F +609,386 shares

    6.43% of the 13F portfolio, value $94,253,142.

    13F-HR 0001681596-25-000005 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2024-12-31
    13F 711,320 shares
    Change vs previous 13F -388,010 shares

    7.61% of the 13F portfolio, value $62,396,990.

    13F-HR 0001681596-25-000002 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2024-09-30
    13F 1,099,330 shares
    Change vs previous 13F -136,700 shares

    9.12% of the 13F portfolio, value $91,936,968.

    13F-HR 0001681596-24-000016 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-06-30
    13F 1,236,030 shares
    Change vs previous 13F -86,710 shares

    9.91% of the 13F portfolio, value $94,012,442.

    13F-HR 0001681596-24-000006 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-03-31
    13F/A 1,322,740 shares
    Change vs previous 13F +179,080 shares

    9.72% of the 13F portfolio, value $95,012,414.

    13F-HR/A 0001681596-24-000012 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2023-12-31
    13F/A 1,143,660 shares
    Change vs previous 13F +41,970 shares

    8.7% of the 13F portfolio, value $85,465,711.

    13F-HR/A 0001681596-24-000010 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2023-09-30
    13F/A 1,101,690 shares
    Change vs previous 13F +536,480 shares

    8.6% of the 13F portfolio, value $74,947,970.

    13F-HR/A 0001681596-24-000009 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2023-06-30
    13F/A 565,210 shares
    Change vs previous 13F not available

    9.14% of the 13F portfolio, value $82,288,923.

    13F-HR/A 0001681596-24-000008 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).